Home FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL
 

Keywords :   


FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

2014-08-29 14:50:24| Biotech - Topix.net

Mylan Inc. today announced that its abbreviated new drug application for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration .

Tags: filing generic accepts anda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
03.07Keep livestock safe during hurricane season with an emergency plan
03.07Making the most of forage resources
03.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Forecast Discussion Number 17
02.07Hurricane Beryl Forecast Advisory Number 17
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
More »